TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production
- PMID: 16034103
- DOI: 10.4049/jimmunol.175.3.1636
TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production
Abstract
NK cells express receptors that allow them to recognize pathogens and activate effector functions such as cytotoxicity and cytokine production. Among these receptors are the recently identified TLRs that recognize conserved pathogen structures and initiate innate immune responses. We demonstrate that human NK cells express TLR3, TLR7, and TLR8 and that these receptors are functional. TLR3 is expressed at the cell surface where it functions as a receptor for polyinosinic acid:cytidylic acid (poly(I:C)) in a lysosomal-independent manner. TLR7/8 signaling is sensitive to chloroquine inhibition, indicating a requirement for lysosomal signaling as for other cell types. Both R848, an agonist of human TLR7 and TLR8, and poly(I:C) activate NK cell cytotoxicity against Daudi target cells. However, IFN-gamma production is differentially regulated by these TLR agonists. In contrast to poly(I:C), R848 stimulates significant IFN-gamma production by NK cells. This is accessory cell dependent and is inhibited by addition of a neutralizing anti-IL-12 Ab. Moreover, stimulation of purified monocyte populations with R848 results in IL-12 production, and reconstitution of purified NK cells with monocytes results in increased IFN-gamma production in response to R848. In addition, we demonstrate that while resting NK cells do not transduce signals directly in response to R848, they can be primed to do so by prior exposure to either IL-2 or IFN-alpha. Therefore, although NK cells can be directly activated by TLRs, accessory cells play an important and sometimes essential role in the activation of effector functions such as IFN-gamma production and cytotoxicity.
Similar articles
-
Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.J Immunol. 2007 Sep 15;179(6):3472-9. doi: 10.4049/jimmunol.179.6.3472. J Immunol. 2007. PMID: 17804388
-
APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA.J Immunol. 2004 Jan 1;172(1):138-43. doi: 10.4049/jimmunol.172.1.138. J Immunol. 2004. PMID: 14688319
-
Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.Int Immunol. 2007 Mar;19(3):311-20. doi: 10.1093/intimm/dxl148. Epub 2007 Feb 7. Int Immunol. 2007. PMID: 17289654
-
Regulation of dendritic cell function through Toll-like receptors.Curr Mol Med. 2003 Jun;3(4):373-85. doi: 10.2174/1566524033479726. Curr Mol Med. 2003. PMID: 12776992 Review.
-
Regulatory pathways involved in the infection-induced production of IFN-gamma by NK cells.Microbes Infect. 2002 Dec;4(15):1531-8. doi: 10.1016/s1286-4579(02)00036-9. Microbes Infect. 2002. PMID: 12505525 Review.
Cited by
-
Rhomboid domain-containing protein 3 is a negative regulator of TLR3-triggered natural killer cell activation.Proc Natl Acad Sci U S A. 2013 May 7;110(19):7814-9. doi: 10.1073/pnas.1220466110. Epub 2013 Apr 22. Proc Natl Acad Sci U S A. 2013. PMID: 23610400 Free PMC article.
-
Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.Respir Res. 2021 Apr 29;22(1):133. doi: 10.1186/s12931-021-01722-y. Respir Res. 2021. PMID: 33926483 Free PMC article. Review.
-
Decreased Expression of CD314 by NK Cells Correlates with Their Ability to Respond by Producing IFN-γ after BCG Moscow Vaccination and Is Associated with Distinct Early Immune Responses.Vaccines (Basel). 2023 Jul 28;11(8):1297. doi: 10.3390/vaccines11081297. Vaccines (Basel). 2023. PMID: 37631865 Free PMC article.
-
Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16- subset.J Immunother Cancer. 2022 Jan;10(1):e003385. doi: 10.1136/jitc-2021-003385. J Immunother Cancer. 2022. PMID: 35091452 Free PMC article.
-
Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer.Cancer. 2014 Mar 1;120(5):624-32. doi: 10.1002/cncr.28380. Epub 2013 Nov 12. Cancer. 2014. PMID: 24222079 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous